Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Virus-Cell Interactions

The Sheep Tetherin Paralog oBST2B Blocks Envelope Glycoprotein Incorporation into Nascent Retroviral Virions

Lita Murphy, Mariana Varela, Sophie Desloire, Najate Ftaich, Claudio Murgia, Matthew Golder, Stuart Neil, Thomas E. Spencer, Sarah K. Wootton, Dimitri Lavillette, Christophe Terzian, Massimo Palmarini, Frédérick Arnaud
S. R. Ross, Editor
Lita Murphy
aMedical Research Council, University of Glasgow, Centre for Virus Research, Glasgow, Scotland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mariana Varela
aMedical Research Council, University of Glasgow, Centre for Virus Research, Glasgow, Scotland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sophie Desloire
bUMR754, Université Claude Bernard Lyon 1, Institut National de la Recherche Agronomique, Ecole Pratique des Hautes Etudes, SFR BioSciences Gerland, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Najate Ftaich
bUMR754, Université Claude Bernard Lyon 1, Institut National de la Recherche Agronomique, Ecole Pratique des Hautes Etudes, SFR BioSciences Gerland, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudio Murgia
aMedical Research Council, University of Glasgow, Centre for Virus Research, Glasgow, Scotland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Golder
aMedical Research Council, University of Glasgow, Centre for Virus Research, Glasgow, Scotland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stuart Neil
cDepartment of Infectious Diseases, King's College London School of Medicine, London, England
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas E. Spencer
dDepartment of Animal Sciences and Center for Reproductive Biology, Washington State University, Pullman, Washington, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah K. Wootton
eDepartment of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dimitri Lavillette
fUMR5557 Microbial Ecology, Centre National de la Recherche Scientifique, Université Claude Bernard Lyon 1, Villeurbanne, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christophe Terzian
bUMR754, Université Claude Bernard Lyon 1, Institut National de la Recherche Agronomique, Ecole Pratique des Hautes Etudes, SFR BioSciences Gerland, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Massimo Palmarini
aMedical Research Council, University of Glasgow, Centre for Virus Research, Glasgow, Scotland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frédérick Arnaud
bUMR754, Université Claude Bernard Lyon 1, Institut National de la Recherche Agronomique, Ecole Pratique des Hautes Etudes, SFR BioSciences Gerland, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. R. Ross
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JVI.02751-14
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIG 1
    • Open in new tab
    • Download powerpoint
    FIG 1

    oBST2A and -2B have different biological features. (A) Alignment of the amino acid sequences of the ovine BST2 proteins (oBST2A and -2B). An asterisk (*) indicates an identical amino acid, a period (.) indicates weak similarity, and a colon (:) indicates strong similarity. (B) Schematic diagram illustrating the main structural features and predicted posttranslational modifications of oBST2A and -2B. (C) HEK-293T cells were transiently transfected with expression plasmids for oBST2A-HA or -2B-HA. Cell lysates were harvested and incubated in the presence and absence of PNGase F overnight. Proteins were then separated by SDS-PAGE and visualized by Western blotting using an HA antibody. γ-Tubulin was used as a sample-loading control. (D) Confocal microscopy images of oBST2A-HA and oBST2B-HA in transiently transfected CPT-Tert cells display two different patterns: (i) dispersed within the cytoplasm and cell membrane and (ii) concentrated in a perinuclear region. Scale bars in both panels represent 10 μm. (E) Graph representing the number (%) of cells in which oBST2A-HA- and oBST2B-HA-staining patterns were counted as dispersed or concentrated. At least 75 cells in random fields from two independent experiments were scored.

  • FIG 2
    • Open in new tab
    • Download powerpoint
    FIG 2

    oBST2B localizes to the Golgi apparatus. (A) CPT-Tert cells were transfected with oBST2A-HA or oBST2B-HA and analyzed 18 h after transfection by confocal microscopy using, respectively, antibodies against the HA epitope (to detect oBST2A-HA or oBST2B-HA protein) and the Golgi markers: p115, giantin, TGN46, and appropriate secondary conjugated antibodies. Scale bars in all panels represent 10 μm. (B) Colocalization of oBST2A-HA and oBST2B-HA with Golgi markers was measured in at least 50 cells from two independent experiments with Image-Pro Plus software using Pearson's correlation coefficient. Any values above 0.5 were regarded as representing significant colocalization.

  • FIG 3
    • Open in new tab
    • Download powerpoint
    FIG 3

    oBST2B localization is altered by treatment with brefeldin A. (A) CPT-Tert cells were transfected with oBST2B-HA expression plasmids. Eighteen hours after transfection, cells were treated or not treated with 200 ng/ml of brefeldin A for 90 min, fixed, and analyzed by confocal microscopy using antibodies to the giantin Golgi marker and the HA epitope as indicated. Two different staining patterns were observed: (i) dispersed within the cytoplasm and (ii) concentrated in a perinuclear region. Scale bars in all panels represent 10 μm. (B) Graph representing the number (%) of cells in which oBST2B-HA and giantin staining were observed to be concentrated as opposed to dispersed. At least 100 cells from two independent experiments were evaluated randomly.

  • FIG 4
    • Open in new tab
    • Download powerpoint
    FIG 4

    oBST2A and oBST2B both redistribute intracellular Env and Gag. CPT-Tert cells were transfected with the full-length JSRV21 expression plasmid with either an empty plasmid or expression plasmids for oBST2A-HA or oBST2B-HA. CPT-Tert cells were also transfected with an expression plasmid for oBST2B-HA in order to assess the influence of this protein on the intracellular distribution of cellular cadherins. Upon immunostaining with the appropriate antibody, the intracellular distributions of Env (A), Gag (B), and cadherins (C) were scored and counted as concentrated or dispersed or at the plasma membrane using confocal microscopy. Scale bars in all panels represent 10 μm. Graphs represent the number (%) of cells in which the intracellular distribution of Env (A), Gag (B), or cadherins (C) displays a concentrated, dispersed, or plasma membrane staining pattern. At least 100 cells in random fields from two independent experiments were counted.

  • FIG 5
    • Open in new tab
    • Download powerpoint
    FIG 5

    oBST2B colocalizes with JSRV Env. (A) CPT-Tert cells transfected with the JSRV Env-CFlag-expressing plasmid with either an empty pcDNA3.1 vector, pDsRed-Golgi, pCIoBST2A-HA, or -2B-HA were analyzed by confocal microscopy. The intracellular distribution of Env-CFlag was scored as concentrated, dispersed, or at the plasma membrane using confocal microscopy. Scale bars in all panels represent 10 μm. The graph represents the number (%) of cells in which the intracellular distribution of Env-CFlag displays a concentrated, dispersed, or plasma membrane staining pattern. At least 100 cells in random fields from two independent experiments were counted. (B) Representative pictures of CPT-Tert cells coexpressing Env-CFlag with DsRed-Golgi, oBST2A-HA, or oBST2B-HA. Colocalization of Env-CFlag with oBST2B-HA in a perinuclear region was measured in at least 50 cells from two independent experiments with Image-Pro Plus software using Pearson's correlation coefficient (P. Coef.). Any value above 0.5 was regarded as significant. Scale bars in all panels represent 10 μm.

  • FIG 6
    • Open in new tab
    • Download powerpoint
    FIG 6

    oBST2B reduces the incorporation of JSRV Env into virions. (A) Representative Western blots of concentrated viral particles from supernatants (virus) and cellular extracts (lysates) of mock-CPT-Tert-transfected cells (M) or cells transfected with expression plasmids for full-length JSRV21 and 1 μg of expression plasmids for oBST2B (2B) or oBST2B-HA (2B-HA) or an empty pcDNA3.1 control (−). Blots were incubated with the appropriate antisera as indicated in each panel. (B) Viral-particle release and Env incorporation in the presence of an increasing amount of oBST2B or oBST2B-HA (0.25 μg to 2 μg) were detected with an anti-Gag (CA) and anti-Env (SU) antibodies and quantified by chemifluorescence. (C and D) Values for CA and SU expression were related to values obtained for cells cotransfected with an expression plasmid for JSRV21 and the empty pcDNA3.1 plasmid (taken as 100). Blots represent the ratios of SU/CA expression calculated from three independent experiments. (C) A two-way statistical ANOVA shows that there is no difference in the relative SU/CA ratios between cells transfected with oBST2B- and oBST2B-HA-expressing plasmids (P = 0.74). (D) These ratios are negatively correlated with the quantity of transfected plasmids (P = 0.006). Open circles are ratio values; black circles (C) or horizontal bars (D) represent the mean ratios of the data obtained.

  • FIG 7
    • Open in new tab
    • Download powerpoint
    FIG 7

    oBST2B reduces infectivity of MLV-based vectors pseudotyped by JSRV Env or VSV-G glycoproteins. (A) Representative Western blots of cellular extracts (lysates) of CPT-Tert transfected with 1 μg of the expression plasmid for oBST2B-HA [CPT (1 μg)] or 293T cells stably expressing oBST2B-HA (293T/B-HA). oBST2B-HA was detected using an anti-HA antibody. α-Tubulin (α-Tub) was used as a sample-loading control. (B) 293T/B-HA cells were analyzed by confocal microscopy using antibodies to the HA epitope and cadherins, as indicated in the panel. The scale bar represents 10 μm. (C) Western blots of concentrated viral particles recovered from the supernatants of 293T or 293T/B-HA cells (indicated by a minus or a plus sign, respectively) transfected with the expression plasmids in the amounts (5 μg, 2 μg, or 0.8 μg) reported above the blots. Blots were incubated with anti-MLV-CA and anti-JSRV-SU or anti-VSV-G antibodies, as indicated. Each experiment was repeated independently three times, and representative Western blots are shown. Viral-particle release and Env incorporation of JSRVpp-2 μg and JSRVpp-0.8 μg produced in 293T and 293T/B-HA cells were assessed by chemifluorescence. Values for CA and SU expression in 293T/B-HA cells were related to values obtained in 293T control cells (arbitrarily set as 100%). The graph represents the SU/CA ratios of JSRVpp-2 μg and JSRVpp-0.8 μg produced in 293T/B-HA cells. Note that there is a statistically significant difference (P = 0.01, calculated by one-way ANOVA) in 293T/B-HA cells that depends on the amount of JSRV Env expression plasmid transfected. Open circles indicate ratio values, while black horizontal bars represent the mean ratio values of the data obtained. (D) NoEnvpp-, JSRVpp-, and VSVpp-infected CPT-Tert cells were analyzed by fluorescence-activated cell sorter (FACS) at 72 h postinfection to quantify the percentage of GFP-positive cells. The percentage of cells infected with JSRVpp and VSVpp produced in control 293T cells was designated 100% of infectivity. Experiments were performed independently at least three times with two biological replicates for each CPT-Tert infection. Bars indicate standard errors.

PreviousNext
Back to top
Download PDF
Citation Tools
The Sheep Tetherin Paralog oBST2B Blocks Envelope Glycoprotein Incorporation into Nascent Retroviral Virions
Lita Murphy, Mariana Varela, Sophie Desloire, Najate Ftaich, Claudio Murgia, Matthew Golder, Stuart Neil, Thomas E. Spencer, Sarah K. Wootton, Dimitri Lavillette, Christophe Terzian, Massimo Palmarini, Frédérick Arnaud
Journal of Virology Dec 2014, 89 (1) 535-544; DOI: 10.1128/JVI.02751-14

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Sheep Tetherin Paralog oBST2B Blocks Envelope Glycoprotein Incorporation into Nascent Retroviral Virions
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The Sheep Tetherin Paralog oBST2B Blocks Envelope Glycoprotein Incorporation into Nascent Retroviral Virions
Lita Murphy, Mariana Varela, Sophie Desloire, Najate Ftaich, Claudio Murgia, Matthew Golder, Stuart Neil, Thomas E. Spencer, Sarah K. Wootton, Dimitri Lavillette, Christophe Terzian, Massimo Palmarini, Frédérick Arnaud
Journal of Virology Dec 2014, 89 (1) 535-544; DOI: 10.1128/JVI.02751-14
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514